Senses Disorder TRIZ Cases
- N-Substituted Phthalamic Acids as Sortilin Inhibitors
N-substituted phthalamic acid derivatives block Sortilin-mediated interactions to alleviate neurodegenerative and inflammatory processes.
- Bicyclic Pyridone Lactams for Selective RIP1 Kinase Inhibition
Bicyclic pyridone lactam compounds selectively inhibit RIP1 kinase to address insufficient specificity and efficacy of existing necrostatins.
- Implantable Intraocular Drug Delivery Scaffold
A segmented intraocular scaffold provides sustained drug delivery to the retina, eliminating repeated injections and patient discomfort.
- Heterocyclic Urea Compounds for Selective GSK-3β Inhibition
Urea derivatives achieve selective GSK-3β inhibition to treat neurodegenerative diseases, resolving isoform selectivity trade-offs.
- Substituted Amide Rho Kinase Inhibitors for Resistant Hypertension
Substituted amide derivatives inhibit Rho kinase activity, providing effective treatment for patients with resistant hypertension.
- Ocular Drug Delivery Device Integrated Membrane Molding
A polymerizable drug release membrane forms directly over a coated drug core during device body molding.
- Implantable Therapeutic Device Porous Reservoir Sustained Release
Segmented porous membranes maintain stable drug concentrations in the eye, eliminating painful bolus injections and infection risks.
- Flavonoid Derivatives Protecting Groups Ischemia
Ester protecting groups modify flavonoids to enhance solubility and pharmacokinetic properties, treating ischemia and reperfusion injuries.
- Deuterated Retinoids for Macular Degeneration Treatment
C20-D3-retinal substrates impede A2E accumulation without delaying dark adaptation, avoiding adverse visual effects.
- Antioxidant Eye Drops for Cataract and Dry Eye Relief
A topical formulation combining astaxanthin, resveratrol, pyruvate, and EGCG in a carbomer gel reduces oxidative stress to delay cataracts.
- Pyrimidine Derivatives Inhibit Choroidal Neovascularization
Pyrimidine derivatives block VEGF signaling pathways, reducing pathological neovascularization and vascular leakage in ocular disorders.
- Modified LCAT Enzyme for Atherosclerosis Treatment
Modified LCAT enzyme increases HDL cholesterol levels to prevent arterial wall accumulation, addressing low HDL limitations in atherosclerosis treatment.
- Multifunctional Radical Quenchers for Mitochondrial ATP Restoration
Novel multifunctional radical quenchers increase ATP concentration in CoQ10 deficient cells through targeted electron donation mechanisms.
- PEDF Treatment for Dry Macular Degeneration
PEDF restores choriocapillaris health and visual acuity while avoiding cardiovascular risks from anti-VEGF therapies.
- Alginate and Proton Pump Inhibitor Composition for BPPV Treatment
A composition combining alginate with a proton pump inhibitor targets inner ear dysfunction through biochemical modulation.
- Substituted Pyrrole Amides Inhibit Alpha v Integrins
Substituted pyrrole amides antagonize alpha v integrin pathways, addressing unmet medical needs in fibrosis and cancer treatment.
- AAV Gene Therapy for Sustained Antibody Expression
Adeno-associated virus vectors deliver therapeutic genes to create permanent tissue depots, eliminating repeated injections and reducing immunogenicity.